Why the Prospa and G8 Education share prices both collapsed recently
We examine the earnings downgrades that contributed to the recent investor sell-off of G8 Education and Prospa stock.
Market musings
Yesterday we discussed how amongst all things: the market loves an earnings upgrade.
As we wrote, it was unsurprising that Appen's share price jumped as much as 14% after the company bumped up its full-year EBITDA guidance: from a shy $85m - $90m to $96m - $99m.
Of course, if the market loves an earnings upgrade, the other near-certainty is that the market absolutely hates an earnings downgrade.
Unsurprisingly then, when fresh-faced Prospa (ASX: PGL) and G8 Education (ASX: GEM) both announced earnings downgrades in the last week – the market was not shy about beating their share prices lower.
Below, we take a look at the details of both downgrades.
Practise trading Australian stocks with an IG demo account now
G8 share price: when assumptions fall away
In August the company remained mostly upbeat, noting the following:
'Balancing the performance of the organic centres with our caution in relation to the market environment, the forecast underlying EBIT range for CY19 is $140m - $145m.'
Had the company achieved such goals – or maybe more relevantly kept that estimate stable – it would have marked a slight increase on the company’s 2018 underlying EBIT of $136.3m. Not a big leap, but at the very least not a decline.
The above guidance however, as the company would later announce, was 'predicated upon occupancy growth of mid 1% pts and wage efficiencies.’
It looks as if G8 hasn’t quite hit those targets, with the company last week announcing that 'full-year underlying EBIT forecast is now expected to be $131-$134m for the year.’
Investors responded sharply and swiftly, with the G8 Education share price falling 24% since revealing this earnings downgrade to the market.
The G8 Education (ASX: GEM) share price currently trades at the $1.94 mark – well below its February high of $3.63 per share.
Prospa share price: earnings not so prosperous
Prospa Group Limited (ASX: PGL) listed on the ASX on June 11. The prospectus forecast 1H 2020 originations of $297.4m; revenues of $88.0m and EBITDA (pro forma) of $11.3m.
Good numbers, the market rated, as the Prospa share price ran as high as $5.090. Then, the music stopped. Or maybe more accurately: slowed.
Prospa yesterday revealed to the market that while 1H 2020 originations were actually set to come in a little higher than previously flagged: now at $298.2m; revenue and earnings both were expected to now come in significantly lower. Specifically, 1H 2020 revenue was now expected to come in at around $75.0m, while earnings (EBITDA) was expected even lower at just $4.0m.
The market punished this downgrade accordingly, bidding the stock down as much as 28.57% in the aftermath. PGL currently trades at $2.775 per share.
This information has been prepared by IG, a trading name of IG Limited. In addition to the disclaimer below, the material on this page does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. IG accepts no responsibility for any use that may be made of these comments and for any consequences that result. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. Any research provided does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it. It has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication. Although we are not specifically constrained from dealing ahead of our recommendations we do not seek to take advantage of them before they are provided to our clients.
CFDs are a leveraged products. CFD trading may not be suitable for everyone and can result in losses that exceed your initial deposit, so please ensure that you fully understand the risks involved.
Act on stock opportunities today
Go long or short on thousands of international stocks with CFDs.
- Get full exposure for a comparatively small deposit
- Trade on spreads from just 0.1%
- Get greater order book visibility with direct market access
See opportunity on a stock?
Try a risk-free trade in your demo account, and see whether you’re on to something.
- Log in to your demo
- Try a risk-free trade
- See whether your hunch pays off
See opportunity on a stock?
Don’t miss your chance – upgrade to a live account to take advantage.
- Trade a huge range of popular stocks
- Analyse and deal seamlessly on fast, intuitive charts
- See and react to breaking news in-platform
See opportunity on a stock?
Don’t miss your chance. Log in to take advantage while conditions prevail.
Live prices on most popular markets
- Forex
- Shares
- Indices
Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 15 mins.
